Clinical Trials
4 trialsNCT05828381 2023-04-25
Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer
Fujian Medical University Union Hospital
Phase 2 Unknown
NCT04460066 2022-05-04
A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.
Lee's Pharmaceutical Limited
Phase 1/2 Unknown
NCT05007145 2021-12-21
REVO
Fujian Cancer Hospital
Phase 2 Unknown
NCT04177875 2019-11-26
T+TP
Tongji Hospital
Phase 2 Unknown